ACE and acute myocardial infarction: Acute myocardial infarction, chronic heart failure, and medications like ACE inhibitors/ARBs and calcium channel blockers increased risk, suggesting COVID-19 interaction with cardiometabolic conditions worsens autonomic dysfunction.